Disease-modifying drugs, multiple sclerosis and infection-related healthcare use in British Columbia, Canada: a population-based studyResearch in context

Disease-modifying drugs, multiple sclerosis and infection-related healthcare use in British Columbia, Canada: a population-based studyResearch in context

Summary: Background: Much remains unknown surrounding the disease-modifying drugs (DMDs) used to treat multiple sclerosis and infection-related healthcare use in the ‘real-world’ setting. We examined if DMD exposure was associated with altered infection-related healthcare use. Methods: We assessed...

Full description

Bibliographic Details
Main Authors: Jonas Graf, Huah Shin Ng, Feng Zhu, Yinshan Zhao, José MA. Wijnands, Charity Evans, John D. Fisk, Ruth Ann Marrie, Helen Tremlett
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:The Lancet Regional Health. Americas
Subjects:
Multiple sclerosis
Disease-modifying drugs
Infections
Healthcare use
Online Access:http://www.sciencedirect.com/science/article/pii/S2667193X23002417

Similar Items

Similar Items